The subcutaneous tumor transplantation experiment showed that compared with the NC group, the growth rate of tumors in in vivo conditions significantly slowed down (Figure 4B), while the tumor weight and volume obviously reduced (Figure 4C) in tumor-bearing mice injected with C-MYC knock-down ovarian cancer cells. The gene discussed is MYC; the disease is ovarian carcinoma.